These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

914 related items for PubMed ID: 8035346

  • 1. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 2. [Systemic and regional hemodynamic effects of a new angiotensin converting enzyme and neutral endopeptidase mixed inhibitor, alatriopril, in the dog].
    Richard V, Lecomte JM, Thuillez C.
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1275-9. PubMed ID: 8129543
    [Abstract] [Full Text] [Related]

  • 3. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 5. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [Abstract] [Full Text] [Related]

  • 6. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B, Schoemaker RG, Buikema H, de Zeeuw D, van Veldhuisen DJ, van Gilst WH.
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction.
    Marie C, Mossiat C, Gros C, Schwartz JC, Lecomte JM, Bralet J.
    Cardiovasc Res; 1999 Mar; 41(3):544-53. PubMed ID: 10435026
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
    Maki T, Nasa Y, Tanonaka K, Takahashi M, Takeo S.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
    [Abstract] [Full Text] [Related]

  • 10. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin I converting enzyme inhibitors and cardiac remodeling.
    van Krimpen C, Schoemaker RG, Cleutjens JP, Smits JF, Struyker-Boudier HA, Bosman FT, Daemen MJ.
    Basic Res Cardiol; 1991 Jan; 86 Suppl 1():149-55. PubMed ID: 1827981
    [Abstract] [Full Text] [Related]

  • 12. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [Abstract] [Full Text] [Related]

  • 13. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 14. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
    Helin K, Tikkanen I, Hohenthal U, Fyhrquist F.
    Eur J Pharmacol; 1994 Oct 24; 264(2):135-41. PubMed ID: 7851475
    [Abstract] [Full Text] [Related]

  • 16. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
    Gros C, Noël N, Souque A, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Lecomte JM, Bralet J.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4210-4. PubMed ID: 1851998
    [Abstract] [Full Text] [Related]

  • 17. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

  • 18. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
    Wegner M, Hirth-Dietrich C, Stasch JP.
    Cardiovasc Res; 1996 Jun 19; 31(6):891-8. PubMed ID: 8759244
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C, Mossiat C, Lecomte JM, Schwartz JC, Bralet J.
    J Pharmacol Exp Ther; 1995 Dec 19; 275(3):1324-31. PubMed ID: 8531099
    [Abstract] [Full Text] [Related]

  • 20. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE, Blackwell K, Bikhazi A.
    Can J Physiol Pharmacol; 2003 Feb 19; 81(2):142-9. PubMed ID: 12710528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.